Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dare Bioscience Inc (DARE)

Dare Bioscience Inc (DARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,448
  • Shares Outstanding, K 41,596
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,260 K
  • 60-Month Beta 2.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade DARE with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.10
  • Number of Estimates 3
  • High Estimate 0.09
  • Low Estimate -0.23
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +52.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7100 +11.70%
on 02/23/21
2.5800 -25.97%
on 02/09/21
-0.4300 (-18.38%)
since 02/03/21
3-Month
1.1000 +73.64%
on 12/10/20
3.8500 -50.39%
on 01/20/21
+0.4300 (+29.05%)
since 12/03/20
52-Week
0.7500 +154.67%
on 03/19/20
3.8500 -50.39%
on 01/20/21
+0.7700 (+67.54%)
since 03/03/20

Most Recent Stories

More News
Dare Bioscience to Present at the H.C. Wainwright Global Life Sciences Conference

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the H.C. Wainwright...

DARE : 1.9100 (+1.06%)
Dare Bioscience to Participate in Maxim Group's Late Stage Innovations in Women's Health Virtual Event

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion...

DARE : 1.9100 (+1.06%)
Dare Bioscience to Participate at the Women's Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a live panel discussion...

DARE : 1.9100 (+1.06%)
Dare Bioscience to Present at the 2021 BIO CEO & Investor Digital Conference

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor...

DARE : 1.9100 (+1.06%)
Thinking about buying stock in Dare Bioscience, Endra Life Sciences, Lineage Cell Therapeutics, Inuvo Inc, or eMagin Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DARE, NDRA, LCTX, INUV, and EMAN.

EMAN : 4.74 (-2.07%)
INUV : 1.2500 (-10.71%)
LCTX : 2.28 (-1.30%)
DARE : 1.9100 (+1.06%)
NDRA : 2.46 (-6.46%)
Dare Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a fireside chat...

DARE : 1.9100 (+1.06%)
New Strong Sell Stocks for December 30th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

COLM : 102.30 (-0.21%)
AEL : 28.76 (+2.86%)
NK : 26.58 (-6.28%)
DARE : 1.9100 (+1.06%)
PRG : 46.94 (-3.24%)
New Strong Sell Stocks for December 15th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

APD : 262.34 (-1.38%)
UUUU : 5.86 (-5.33%)
CYBR : 148.58 (+0.53%)
GBT : 42.32 (-3.88%)
DARE : 1.9100 (+1.06%)
Dare Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis

DARE-BV1 met the primary endpoint of the study and all pre-specified secondary efficacy endpoints; demonstrated significantly greater clinical cure rates compared to placebo

DARE : 1.9100 (+1.06%)
New Strong Sell Stocks for December 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CZR : 95.56 (+2.77%)
UUUU : 5.86 (-5.33%)
BCML : 17.60 (+2.92%)
ALRN : 1.4500 (-5.84%)
DARE : 1.9100 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dare Bioscience, Inc. is a healthcare company. It involved in the development and commercialization of products in women's reproductive health. Dare Bioscience, Inc., formerly known as Cerulean Pharma Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 2.2933
2nd Resistance Point 2.1767
1st Resistance Point 2.0433
Last Price 1.9100
1st Support Level 1.7933
2nd Support Level 1.6767
3rd Support Level 1.5433

See More

52-Week High 3.8500
Fibonacci 61.8% 2.6658
Fibonacci 50% 2.3000
Fibonacci 38.2% 1.9342
Last Price 1.9100
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar